دورية أكاديمية
أعرض في EDS

A Model of iPSC-Derived Macrophages with TNFAIP3 Overexpression Reveals the Peculiarities of TNFAIP3 Protein Expression and Function in Human Macrophages.

التفاصيل البيبلوغرافية
العنوان: A Model of iPSC-Derived Macrophages with TNFAIP3 Overexpression Reveals the Peculiarities of TNFAIP3 Protein Expression and Function in Human Macrophages.
المؤلفون: Sheveleva O; Laboratory of Cellular and Molecular Basis of Histogenesis, Koltzov Institute of Developmental Biology of Russian Academy of Sciences, Vavilova Str., 26, 119334 Moscow, Russia., Protasova E; Laboratory of Cellular and Molecular Basis of Histogenesis, Koltzov Institute of Developmental Biology of Russian Academy of Sciences, Vavilova Str., 26, 119334 Moscow, Russia., Nenasheva T; Laboratory of Cellular and Molecular Basis of Histogenesis, Koltzov Institute of Developmental Biology of Russian Academy of Sciences, Vavilova Str., 26, 119334 Moscow, Russia., Butorina N; Laboratory of Cellular and Molecular Basis of Histogenesis, Koltzov Institute of Developmental Biology of Russian Academy of Sciences, Vavilova Str., 26, 119334 Moscow, Russia., Melnikova V; Laboratory of Comparative Developmental Physiology, Koltzov Institute of Developmental Biology of Russian Academy of Sciences, Vavilova Str., 26, 119334 Moscow, Russia., Gerasimova T; Laboratory of Cellular and Molecular Basis of Histogenesis, Koltzov Institute of Developmental Biology of Russian Academy of Sciences, Vavilova Str., 26, 119334 Moscow, Russia., Sakovnich O; Laboratory of Cellular and Molecular Basis of Histogenesis, Koltzov Institute of Developmental Biology of Russian Academy of Sciences, Vavilova Str., 26, 119334 Moscow, Russia., Kurinov A; Laboratory of Regeneration Problems, Koltzov Institute of Developmental Biology of Russian Academy of Sciences, Vavilova Str., 26, 119334 Moscow, Russia., Grigor'eva E; Laboratory of Developmental Epigenetics, Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences, Lavrentyev Ave., 10, 630090 Novosibirsk, Russia., Medvedev S; Laboratory of Developmental Epigenetics, Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences, Lavrentyev Ave., 10, 630090 Novosibirsk, Russia., Lyadova I; Laboratory of Cellular and Molecular Basis of Histogenesis, Koltzov Institute of Developmental Biology of Russian Academy of Sciences, Vavilova Str., 26, 119334 Moscow, Russia.
المصدر: International journal of molecular sciences [Int J Mol Sci] 2023 Aug 16; Vol. 24 (16). Date of Electronic Publication: 2023 Aug 16.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Basel, Switzerland : MDPI, [2000-
مواضيع طبية MeSH: Tumor Necrosis Factor-alpha* , Induced Pluripotent Stem Cells*, Humans ; Tumor Necrosis Factor alpha-Induced Protein 3/genetics ; Macrophages ; Inflammation
مستخلص: Macrophages play a crucial role in the development and control of inflammation. Understanding the mechanisms balancing macrophage inflammatory activity is important to develop new strategies for treating inflammation-related diseases. TNF-α-induced protein 3 (TNFAIP3, A20) is a negative regulator of intracellular inflammatory cascades; its deficiency induces hyper-inflammatory reactions. Whether A20 overexpression can dampen macrophage inflammatory response remains unclear. Here, we generated human-induced pluripotent stem cells with tetracycline-inducible A20 expression and differentiated them into macrophages (A20-iMacs). A20-iMacs displayed morphology, phenotype, and phagocytic activity typical of macrophages, and they displayed upregulated A20 expression in response to doxycycline. A20 overexpression dampened the A20-iMac response to TNF-α, as shown by a decreased expression of IL1B and IL6 mRNA. A dynamic analysis of A20 expression following the generation of A20-iMacs and control iMacs showed that the expression declined in iMacs and that iMacs expressed a lower molecular weight form of the A20 protein (~70 kDa) compared with less differentiated cells (~90 kDa). A low-level expression of A20 and the predominance of a low-molecular-weight A20 form were also characteristic of monocyte-derived macrophages. The study for the first time developed a model for generating macrophages with an inducible expression of a target gene and identified the peculiarities of A20 expression in macrophages that likely underlie macrophage preparedness for inflammatory reactivity. It also suggested the possibility of mitigating inflammatory macrophage responses via A20 overexpression.
References: BMC Cardiovasc Disord. 2022 Jan 16;22(1):10. (PMID: 35034631)
Stem Cell Res. 2020 Oct;48:101952. (PMID: 32805537)
J Cell Mol Med. 2022 Aug;26(16):4591-4601. (PMID: 35841281)
Nat Rev Immunol. 2011 Oct 14;11(11):723-37. (PMID: 21997792)
Stem Cell Reports. 2017 Feb 14;8(2):334-345. (PMID: 28111278)
J Neuroimmunol. 2014 Jul 15;272(1-2):99-102. (PMID: 24852325)
Int J Cancer. 2011 May 15;128(10):2495-500. (PMID: 20669229)
Nat Immunol. 2004 Oct;5(10):1052-60. (PMID: 15334086)
Front Immunol. 2014 Oct 07;5:491. (PMID: 25339958)
Biochem Pharmacol. 2010 Dec 15;80(12):2009-20. (PMID: 20599425)
Nature. 1990 Feb 15;343(6259):657-9. (PMID: 1689462)
Science. 2015 Jan 23;347(6220):1260419. (PMID: 25613900)
J Immunol. 2009 Jun 15;182(12):7718-28. (PMID: 19494296)
Neurotox Res. 2017 Jul;32(1):1-7. (PMID: 28337659)
Ann Rheum Dis. 2017 Mar;76(3):585-592. (PMID: 27551052)
Nature. 1970 Aug 15;227(5259):680-5. (PMID: 5432063)
Exp Hematol. 2015 Oct;43(10):838-848.e3. (PMID: 26101162)
BMC Immunol. 2007 Jan 12;8:1. (PMID: 17222336)
PLoS One. 2013 Sep 02;8(9):e73153. (PMID: 24023826)
Nat Immunol. 2020 Apr;21(4):422-433. (PMID: 32205880)
Cell Stem Cell. 2012 Apr 6;10(4):440-54. (PMID: 22482508)
Am J Respir Crit Care Med. 2014 Jan 15;189(2):167-82. (PMID: 24279725)
Int J Mol Sci. 2020 Apr 18;21(8):. (PMID: 32325694)
Stem Cell Res. 2018 Dec;33:199-205. (PMID: 30445411)
Int J Mol Sci. 2022 Dec 16;23(24):. (PMID: 36555728)
Front Immunol. 2020 Jun 04;11:1016. (PMID: 32582159)
Rheumatology (Oxford). 2017 May 1;56(5):835-843. (PMID: 28158872)
Front Immunol. 2022 Jan 26;13:804401. (PMID: 35154120)
Cell Biosci. 2022 Jun 20;12(1):96. (PMID: 35725499)
Stem Cells. 2013 Jun;31(6):1033-9. (PMID: 23401375)
Front Cell Dev Biol. 2021 Jun 02;9:640703. (PMID: 34150747)
J Leukoc Biol. 2002 Sep;72(3):417-28. (PMID: 12223508)
J Clin Pathol. 2018 Jan;71(1):88-91. (PMID: 29180509)
Development. 2009 Mar;136(6):1029-38. (PMID: 19234065)
Diabetes. 2006 Sep;55(9):2491-501. (PMID: 16936197)
Cells. 2023 Jan 11;12(2):. (PMID: 36672212)
Cell Mol Immunol. 2021 Mar;18(3):579-587. (PMID: 32934339)
Ann Rheum Dis. 2010 Nov;69(11):1958-64. (PMID: 20511617)
Stem Cell Res. 2019 May;37:101434. (PMID: 30999275)
J Exp Med. 2015 Feb 9;212(2):203-16. (PMID: 25624445)
J Allergy Clin Immunol. 2017 Jun;139(6):1914-1922. (PMID: 27845235)
J Allergy Clin Immunol. 2018 Jan;141(1):339-349.e11. (PMID: 28587749)
Hum Gene Ther. 2021 Jan;32(1-2):77-95. (PMID: 33023317)
Arthritis Res Ther. 2009;11(2):R42. (PMID: 19292917)
J Biol Chem. 1990 Feb 15;265(5):2973-8. (PMID: 2406243)
Nature. 2014 Aug 7;512(7512):69-73. (PMID: 25043000)
Cell Stem Cell. 2010 Jul 2;7(1):90-100. (PMID: 20621053)
Methods Mol Biol. 2018;1784:187-195. (PMID: 29761400)
Stem Cells Int. 2015;2015:628368. (PMID: 25767512)
Aging (Albany NY). 2020 Nov 20;12(23):24242-24254. (PMID: 33226960)
Front Immunol. 2018 Feb 21;9:104. (PMID: 29515565)
Stem Cell Reports. 2020 May 12;14(5):940-955. (PMID: 32359446)
Am J Physiol Lung Cell Mol Physiol. 2019 Mar 1;316(3):L456-L469. (PMID: 30543305)
Stem Cell Rev Rep. 2014 Oct;10(5):697-711. (PMID: 24913281)
PLoS One. 2007 Jun 20;2(6):e533. (PMID: 17579707)
Nat Immunol. 2019 Oct;20(10):1299-1310. (PMID: 31534238)
Stem Cell Reports. 2019 Oct 8;13(4):590-598. (PMID: 31543470)
Annu Rev Physiol. 2017 Feb 10;79:593-617. (PMID: 27959618)
Front Mol Neurosci. 2019 Sep 19;12:222. (PMID: 31607859)
Transfus Med Hemother. 2017 Jun;44(3):135-142. (PMID: 28626364)
Front Immunol. 2021 Aug 12;12:708186. (PMID: 34456917)
FEBS Lett. 2004 Oct 8;576(1-2):86-90. (PMID: 15474016)
Cytotechnology. 2020 Oct;72(5):649-663. (PMID: 32519278)
J Leukoc Biol. 2018 Feb 13;:. (PMID: 29437254)
Ann Rheum Dis. 2018 May;77(5):728-735. (PMID: 29317407)
Nat Immunol. 2008 Mar;9(3):263-71. (PMID: 18223652)
Mol Cell Biol. 2002 Sep;22(17):6034-45. (PMID: 12167698)
Pediatr Res. 2007 Nov;62(5):542-6. (PMID: 17805211)
Gene Ther. 2011 Sep;18(9):874-83. (PMID: 21430784)
Science. 2000 Sep 29;289(5488):2350-4. (PMID: 11009421)
Cancer Immunol Res. 2016 Mar;4(3):248-58. (PMID: 26714554)
Arthritis Rheum. 2012 Aug;64(8):2746-52. (PMID: 22488580)
Trends Immunol. 2014 Jan;35(1):22-31. (PMID: 24246475)
Nat Genet. 2011 Aug 14;43(9):908-12. (PMID: 21841782)
Genes Immun. 2011 Apr;12(3):176-82. (PMID: 21326317)
Sci Rep. 2017 Nov 9;7(1):15195. (PMID: 29123113)
Front Immunol. 2021 Nov 26;12:780689. (PMID: 34899744)
Arthritis Res Ther. 2020 Sep 21;22(1):220. (PMID: 32958016)
J Immunol. 2009 Jul 15;183(2):1384-92. (PMID: 19570823)
Immunity. 2017 Jul 18;47(1):183-198.e6. (PMID: 28723550)
Sci Rep. 2022 May 27;12(1):8928. (PMID: 35624228)
Trends Immunol. 2009 Aug;30(8):383-91. (PMID: 19643665)
Biochem Biophys Res Commun. 2010 Oct 1;400(4):543-7. (PMID: 20804738)
Nature. 2013 Apr 25;496(7446):445-55. (PMID: 23619691)
Nat Rev Immunol. 2012 Nov;12(11):774-85. (PMID: 23059429)
Nat Rev Drug Discov. 2022 Nov;21(11):799-820. (PMID: 35974096)
J Biol Chem. 2006 Jan 27;281(4):2095-103. (PMID: 16306043)
Front Immunol. 2020 Nov 03;11:536442. (PMID: 33224133)
Front Physiol. 2017 Aug 23;8:610. (PMID: 28878689)
Immunity. 2015 Jan 20;42(1):55-67. (PMID: 25607459)
Cell Mol Immunol. 2012 Mar;9(2):123-30. (PMID: 22343828)
معلومات مُعتمدة: 075-15-2020-773 Ministry of Science and Higher Education of the Russian Federation; 0088-2021-0016 Ministry of Science and Higher Education of the Russian Federation
فهرسة مساهمة: Keywords: A20; TNFAIP3; doxycycline-inducible gene expression; induced pluripotent stem cells; inflammatory response; macrophages derived from induced pluripotent stem cells
المشرفين على المادة: 0 (Tumor Necrosis Factor-alpha)
EC 3.4.19.12 (Tumor Necrosis Factor alpha-Induced Protein 3)
EC 3.4.19.12 (TNFAIP3 protein, human)
تواريخ الأحداث: Date Created: 20230826 Date Completed: 20230828 Latest Revision: 20230829
رمز التحديث: 20240628
مُعرف محوري في PubMed: PMC10454046
DOI: 10.3390/ijms241612868
PMID: 37629049
قاعدة البيانات: MEDLINE
الوصف
تدمد:1422-0067
DOI:10.3390/ijms241612868